Skip to main content
News > News > Open Therapeutics Integrates Annotation with Hypothesis

Open Therapeutics Integrates Annotation with Hypothesis

Today, Open Therapeutics is announcing the integration of Hypothesis annotation capabilities in Therapoid™, its crowdsourcing platform that enables scientists to collaborate freely on therapeutic biotechnology research.

With these annotation capabilities, scientists from around the world will be able to view and create annotations on Therapoid web pages, developing manuscripts, and completed preprint deposits, both as individuals and as members of collaborative groups.


Screenshot of Open Therapeutics preprint with annotations.


“We welcome Open Therapeutics as a partner,” says Dr. Heather Staines, Hypothesis Director of Partnerships. “One of our primary goals is to facilitate collaboration by enabling a powerful toolchain that researchers can use across the web throughout the research life cycle. That Open Therapeutics decided to integrate annotations across its innovative open science platform speaks to the promise of a standards-based and interoperable collaboration tool.”

Open Therapeutics helps researchers around the world gain access to scientific collaborators, particularly scientists in underserved areas. Therapoid, its open science collaborative ecosystem, is a free web-based platform that crowdsources research around open therapeutic technologies. Free services include pre-publication peer review and a preprint server.

According to Jason E. Barkeloo, Founder and Executive Chairman of Open Therapeutics, “Hypothesis has a proven ability to enable researchers to collaborate via annotating webpages and documents. Our researchers invest time communicating and developing manuscripts. We are excited to offer the Hypothesis annotation tool as an important and critical feature throughout the Therapoid scientific collaborative platform.”

Open Therapeutics also has plans to augment annotation in Therapoid to better support the mobile access necessary for scientists working in diverse locations.


About Open Therapeutics LLC

Open Therapeutics is an open science crowdsourcing firm that creates and attracts therapeutic biotechnologies and provides them free of cost to the global scientific community. The global research community can freely access the technologies and funding to further develop technologies within Therapoid™, its collaborative research platform. The company is headquartered in Minneapolis, MN, with laboratory operations in Covington, KY, and offices in Cincinnati, OH, Amman, Jordan, and Bangalore, India.


Jerome Hamilton, CEO, Open Therapeutics

+1 (651) 900-0412



About Hypothesis

Hypothesis is a US 501(c)3 nonprofit organization dedicated to the development and spread of open, standards-based annotation technologies and practices that enable anyone to annotate anywhere, enabling humans to reason more effectively together through a shared, collaborative discussion layer over all knowledge. Hypothesis is based in San Francisco, CA with a team distributed all over the world.


Heather Staines, Director of Partnerships




We Believe

Open Therapeutics crowdsources orphan and dormant therapeutic intellectual properties (IP) to scientists around the world. The goal is advancing research that ordinarily has not generated a public value or been recognized. This approach particularly helps underserved scientists to collaborate with their more financially capable colleagues.

How open science helps researchers succeed:

Open access, open data, open source, and other open scholarship practices are growing in popularity and necessity. However, widespread adoption of these practices has not yet been achieved. One reason is that researchers are uncertain about how sharing their work will affect their careers.

The review of the literature demonstrates that open science is associated with increases in citations, media attention, potential collaborators, job opportunities, and funding opportunities. These findings are evidence that open science practices bring significant benefits to researchers relative to more traditional closed practices.

Secured By miniOrange